Search research articles
Contact Us
Filters
Showing results (21-30 of 72) with videos related to
Page
of 8
Sort By:
CNS Drug Reviews
|
February 24, 2004
The selective norepinephrine reuptake inhibitor antidepressant reboxetine: pharmacological and clinical profile
Mihály Hajós, Joseph C Fleishaker, Jacqueline K Filipiak-Reisner, et al.
Journal of Clinical Anesthesia
|
October 31, 2007
Parecoxib sodium administered over several days reduces pain after gynecologic surgery via laparotomy
Michael C Snabes, Artur J Jakimiuk, Jan Kotarski, et al.
Anesthesia and Analgesia
|
July 18, 2008
A multiple-day regimen of parecoxib sodium 20 mg twice daily provides pain relief after total hip arthroplasty
Eugene R Viscusi, Joseph S Gimbel, Andreas M Halder, et al.
The Journal of Biological Chemistry
|
August 23, 2002
Actin can act as a cofactor for a viral proteinase in the cleavage of the cytoskeleton
Mark T Brown, Kevin M McBride, Mary Lynn Baniecki, et al.
Arthritis and Rheumatism
|
April 5, 2013
Tanezumab reduces osteoarthritic hip pain: results of a randomized, double-blind, placebo-controlled phase III trial
Mark T Brown, Frederick T Murphy, David M Radin, et al.
The Journal of Pain
|
July 13, 2012
Tanezumab reduces osteoarthritic knee pain: results of a randomized, double-blind, placebo-controlled phase III trial
Mark T Brown, Frederick T Murphy, David M Radin, et al.
Headache
|
September 24, 2005
Valdecoxib for treatment of a single, acute, moderate to severe migraine headache
David Kudrow, H Mikel Thomas, Gary Ruoff, et al.
Pain
|
May 28, 2013
A phase III placebo- and oxycodone-controlled study of tanezumab in adults with osteoarthritis pain of the hip or knee
Egilius L H Spierings, James Fidelholtz, Gernot Wolfram, et al.
Pain
|
September 8, 2014
A phase III placebo- and oxycodone-controlled study of tanezumab in adults with osteoarthritis pain of the hip or knee: response
Egilius L H Spierings, James Fidelholtz, Gernot Wolfram, et al.
International Clinical Psychopharmacology
|
April 19, 2003
Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder
Anita H Clayton, John Zajecka, James M Ferguson, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 72) with videos related to
Sort By:
Page
of 8
CNS Drug Reviews
|
February 24, 2004
The selective norepinephrine reuptake inhibitor antidepressant reboxetine: pharmacological and clinical profile
Mihály Hajós, Joseph C Fleishaker, Jacqueline K Filipiak-Reisner, et al.
Journal of Clinical Anesthesia
|
October 31, 2007
Parecoxib sodium administered over several days reduces pain after gynecologic surgery via laparotomy
Michael C Snabes, Artur J Jakimiuk, Jan Kotarski, et al.
Anesthesia and Analgesia
|
July 18, 2008
A multiple-day regimen of parecoxib sodium 20 mg twice daily provides pain relief after total hip arthroplasty
Eugene R Viscusi, Joseph S Gimbel, Andreas M Halder, et al.
The Journal of Biological Chemistry
|
August 23, 2002
Actin can act as a cofactor for a viral proteinase in the cleavage of the cytoskeleton
Mark T Brown, Kevin M McBride, Mary Lynn Baniecki, et al.
Arthritis and Rheumatism
|
April 5, 2013
Tanezumab reduces osteoarthritic hip pain: results of a randomized, double-blind, placebo-controlled phase III trial
Mark T Brown, Frederick T Murphy, David M Radin, et al.
The Journal of Pain
|
July 13, 2012
Tanezumab reduces osteoarthritic knee pain: results of a randomized, double-blind, placebo-controlled phase III trial
Mark T Brown, Frederick T Murphy, David M Radin, et al.
Headache
|
September 24, 2005
Valdecoxib for treatment of a single, acute, moderate to severe migraine headache
David Kudrow, H Mikel Thomas, Gary Ruoff, et al.
Pain
|
May 28, 2013
A phase III placebo- and oxycodone-controlled study of tanezumab in adults with osteoarthritis pain of the hip or knee
Egilius L H Spierings, James Fidelholtz, Gernot Wolfram, et al.
Pain
|
September 8, 2014
A phase III placebo- and oxycodone-controlled study of tanezumab in adults with osteoarthritis pain of the hip or knee: response
Egilius L H Spierings, James Fidelholtz, Gernot Wolfram, et al.
International Clinical Psychopharmacology
|
April 19, 2003
Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder
Anita H Clayton, John Zajecka, James M Ferguson, et al.
Page
of 8